Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals Inc | Chief Accounting Officer | Stock Options (Right to buy) | 17K | $439K | $25.84 | Feb 2, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ONCR | Oncorus, Inc. | May 9, 2023 | 0 | $0 | 3 | May 22, 2023 | Interim CFO |
SNDX | Syndax Pharmaceuticals Inc | Feb 2, 2023 | 1 | $485K | 4 | Feb 3, 2023 | Chief Accounting Officer |
SNDX | Syndax Pharmaceuticals Inc | Feb 1, 2022 | 3 | $470K | 4 | Feb 3, 2022 | Chief Accounting Officer |
SNDX | Syndax Pharmaceuticals Inc | Oct 22, 2021 | 0 | $0 | 3 | Nov 4, 2021 | Chief Accounting Officer |